Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma
This study explores a novel therapeutic strategy for relapsed/refractory (R/R) Burkitt lymphoma (BL) by integrating autologous hematopoietic stem cell transplantation (ASCT) with tandem anti-CD19/CD22 chimeric antigen receptor (CAR) T cell therapy. A 20-year-old Asian male with refractory BL, whose...
Saved in:
| Main Authors: | Xiaodan Luo, Ao Chen, Le Qin, Robert Weinkove, Rong Zhao, Ting Ye, Sihui Chen, Jianli Tang, Jianbo Liu, Jiayu Huang, Boyun Shi, Danyun Yuan, Huo Tan, Dajiang Qin, Zhaoyang Tang, Peng Li, Runhui Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1497736/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01) -
ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01) -
Antigen-Independent Maturation of CD2, CD11a/CD18,CD44, and CD58 Expression on Thymic Emigrants inFetal and Postnatal Sheep
by: Deborah A. Witherden, et al.
Published: (1995-01-01) -
CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies
by: Malgorzata Bobrowicz, et al.
Published: (2024-12-01) -
CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
by: John F. Imbery, et al.
Published: (2024-09-01)